Has Tony Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,267 in general payments to Tony Lin, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tony Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tony Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tony Lin, MD

Orthopaedic Surgery · Longview, WANPI 1043414741

Payments from drug & device makers

$2,267in general payments, 2019–2025

Across 24 payments — averaging $94.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Steelhead Surgical Inc$2K
Stryker$393
Arthrex$134
Left Coast Surgical Inc$66
Bioventus LLC$62
DJO, LLC$43
plus $24 from 1 others

What the payments were for

Food & beverage$1,06747%
Education$1,20053%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Steelhead Surgical Inc	6	$1,544
Stryker	8	$393
Arthrex	1	$134
Left Coast Surgical Inc	2	$66
Bioventus LLC	4	$62
DJO, LLC	2	$43
Heron Therapeutics, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$175

How this compares

$2,267 in reported general payments places this provider in the 45th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington →

Medicare billing

Part B allowed, 2024

$114,163

Medicare patients

239

Services billed

1,797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	57	$681
Oxycodone Hcl	84	$575
Ondansetron OdtOndansetron	46	$384
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	35	$259
Hydromorphone Hcl	19	$210
Cephalexin	15	$160
Pantoprazole Sodium	30	$154
Meloxicam	37	$135
Methocarbamol	12	$65

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Longview

Peter KungLongview$144K
William BarrettRenton$8.2M
James PritchettSeattle$6.4M
Jeffrey RohSeattle$4.7M
James CrutcherSeattle$3.5M
Keith MayoSeattle$3.1M
Matthew SaltzmanSeattle$1.8M
Tim LovellSpokane$1.8M
Timothy AltonRenton$1.8M
Burt YaszaySeattle$1.5M

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →